Clinical trial
A Phase 2 Assessment of Humacyte's Human Acellular Vessel in Patients Needing Vascular Access for Dialysis
NCT04135417 is registered in ClinicalTrials.gov with Humacyte, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Assessment of Humacyte's Human Acellular Vessel in Patients Needing Vascular Access for Dialysis
- Lead sponsor
- Humacyte, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 12, 2019
- Completion date
- March 2, 2022
- Enrollment
- 30 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, hemodialysis, renal failure, vascular access